Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT07268859
Eligibility Criteria:
Inclusion Criteria:
* Between the ages of 18 and 65,
* No severe hearing and vision problems,
* Can speak and understand Turkish,
* Easy to communicate with,
* First-time sufferer of acute coronary syndrome (ACS) for the first time,
* Decided to start ticagrelor therapy,
* Able to adapt to treatment,
* Individuals who volunteered to participate in the research.
Exclusion Criteria:
* Having any problem that prevents you from communicating cognitively, emotionally and verbally,
* Obstructive sleep abnormalities,
* Have a disease that affects respiratory function (stage IV cancer, bronchial asthma, COVID-19, lung cancer, pulmonary edema, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary embolism, pneumonia or bronchitis, etc.),
* With metabolic abnormalities,
* Intubated after the procedure,
* Previously treated with ticagrelor,
* Individuals who did not volunteer to participate in the study. Losses to follow up
* Individuals who wish to leave the study voluntarily.
* Saturation value below 95%,
* The one with the arrest,
* Who will not be able to fulfill the requirements of the work,
* Individuals with life-threatening conditions
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07268859
Study Brief:
Protocol Section:
NCT07268859